(Q46241434)

20 December 2017

editorial

0 references

title

Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how? (English)

1 reference

20 December 2017

author name string

Masakazu Haneda

series ordinal

1

1 reference

20 December 2017

Akizuki Morikawa

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

17 November 2008

1 reference

20 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

20 December 2017

volume

24

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

338-341

1 reference

20 December 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

The diagnosis and racial origin of 394 patients undergoing renal biopsy: an association between Indian race and interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

A1C and survival in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

The pharmacokinetics of pioglitazone in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN616

Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1681/ASN.2006070772

Identifiers

DOI

10.1093/NDT/GFN616

1 reference

20 December 2017

PubMed ID

19015168

1 reference

20 December 2017